Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production

Neuroscience Letters

Volumn 215, Issue 3, 1996, Pages 209-211

  Das, I ^a   Khan, N S ^a   Puri, B K ^a   Hirsch, S R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Dimethylarginines; Nitrate; Nitric oxide; Nitric oxide synthase; Plasma; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030582418     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12972-4     Document Type: Article

References (12)

1. [1] Akbarian, S., Bunney, W.E., Potkin, S.G., Wigal, S.B., Hagman, J.O., Sandman, C.A. and Jones, E.G., Altered distribution of nicotinamide adenine dinucleotide phosphate-diaphorase neurones in frontal lobe of schizophrenics implies disturbances of cortical development, Arch. Gen. Psychiatry, 50 (1993) 169-177.
2. [2] Bloom, F.E., Advancing a neurodevelopemental origin for schizophrenia, Arch. Gen. Psychiatry, 50 (1993) 224-227.
3. [3] Das, I., Khan, N.S., Puri, B.K., de Belleroche, J. and Hirsch, S.R., Elevated platelet calcium and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain, Biochem. Biophys. Res. Commun., 212 (1995) 375-380.
4. [4] Gattaz, W.F., Cramer, H. and Beckmann, H., Low CSF concentrations of cyclic GMP in schizophrenia, Br. J. Psychiatry, 142 (1983) 288-291.
5. 15N]nitrate in biological fluids, Anal. Biochem., 126 (1982) 131-138.
6. [6] Khan, N.S., Das, I., Puri, B.K., de Belleroche, J. and Hirsch, S.R., Presence of a nitric oxide inhibitor in schizophrenic subjects plasma, Schizophrenia Res., 15 (1995) 62-63.
7. [7] Kotani, K., Shu-ichi. U., Sano, A. and Kakimoto, Y., Isolation and identification of methylarginines from bovine brain, J. Neorochem., 58 (1992) 1127-1129.
8. [8] Moncada, S. and Higgs, E.A., Molecular mechanisms and therapeutic strategies related to nitric oxide, FASEB J., 9 (1995) 1319-1330.
9. [9] Olney, J.W. and Farber, N.B., Glutamate receptor dysfunction and schizophrenia, Arch. Gen. Psychiatry, 52 (1995) 998-1007.
10. [10] Reveley, M.A., De Belleroche, J., Recordati, A. and Hirsch, S.R., Increased CSF amino acids and ventricular enlargement in schizophrenia: a preliminary study, Biol. Psychiatry, 22 (1987) 420-423.
11. [11] Smythies, J.R., The transmethylation hypotheses of schizophrenia re-evaluated, Trends Neurosci., 7 (1984) 45-47.
12. [12] Vallance, P., Leone. A., Calver. A., Collier, J. and Moncada, S., Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 339 (1992) 572-575.